ReviewThe Journal of pharmacology and experimental therapeutics2025

Next-generation T cell engagers in oncology: Pharmacologic evolution from bispecific to trispecific antibodies.

Tarek Nahle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.